Find Clinical Trials | Cedars-Sinai

165 results found

Breast

BNT327 in Combination With Chemotherapy in Locally Recurrent, Inoperable or Metastatic TNBC

This study focuses on people who have triple-negative breast cancer (TNBC) that has metastasized to other organs and does not qualify for immunotherapy pembrolizumab treatment. The purpose of the study is to compare the effects ...

Solid Tumors

PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide

This study focuses on children who have a solid tumor that has come back (relapsed) or has not responded to standard treatments (refractory). The purpose of the study is to determine whether a drug called ...

Leukemia, other, Lymphoid Leukemia

Zanubrutinib Plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

This study focuses on people who have chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) that has never been treated before and whose disease has progressed to the point that therapy has been recommended. The ...

Kidney

Stereotactic Ablative Radiation Therapy for Metastatic Unresected Renal Cell Carcinoma Receiving Immunotherapy

This study focuses on people who have renal cell cancer that has spread beyond the kidney and for whom surgery is not currently recommended (or who have chosen not to have surgery). The study aims ...

Pancreas

Expanded Access Program to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib

The purpose of this expanded access program (EAP), also known as “compassionate use,” is to provide access to an experimental medicine called daraxonrasib (RMC-6236) for patients who have been diagnosed with metastatic pancreatic adenocarcinoma. The ...